文献速递妇科

重新定义IVB期宫颈癌:远处淋巴结转移的独特预后与IIIC期相当

Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage IIIC.
PubMed 文献 · Gynecol Oncol · 2025-05-21

该研究纳入2000至2021年6241例转移性宫颈癌患者,分为腹主动脉旁淋巴结转移(PaLM)组、远处淋巴结转移(DLM)组和远处器官转移(DM)组。多因素Cox分析显示DLM组与PaLM组的宫颈癌特异性生存(HR 0.91,P=0.28)和总生存(HR 0.93,P=0.34)相当,而DLM组生存显著优于DM组。作者结论认为仅远处淋巴结转移的宫颈癌应按局部晚期阶段处理,可采用强化局部区域治疗。

要点

  • DLM组6241例中占10.1%(631例),其生存与PaLM组相当。
  • DLM组生存显著优于DM组(CCSS HR 0.54,P<0.001)。
  • DLM组中全子宫切除术和放疗与OS改善独立相关。

核心结论

  • 宫颈癌仅远处淋巴结转移提示为局部区域晚期阶段,不同于其他IVB期形式,可通过强化局部区域治疗达到治愈。

研究设计与样本

  • 研究纳入2000至2021年诊断为转移性宫颈癌的患者,共6241例。
  • 患者分为三组:仅腹主动脉旁淋巴结转移(PaLM)组2079例(33.3%)、仅远处淋巴结转移(DLM)组631例(10.1%)、远处器官转移(DM)组3531例(56.6%)。
  • 采用Kaplan-Meier法估计宫颈癌特异性生存(CCSS)和总生存(OS)。
  • DLM与PaLM患者间采用1:1倾向性评分匹配,使用逻辑回归。
  • 采用单因素和多因素Cox分析识别预后危险因素。

主要发现

  • 多因素Cox回归分析显示,DLM组与PaLM组的CCSS(HR 0.91,P=0.28)和OS(HR 0.93,P=0.34)相当。
  • 与DM组相比,DLM组的CCSS(HR 0.54,P<0.001)和OS(HR 0.58,P<0.001)显著改善。
  • 倾向性评分匹配后,DLM组与PaLM组的CCSS(HR 0.96,P=0.70)和OS(HR 0.95,P=0.61)仍相当。
  • 在632例DLM患者中,全子宫切除术(HR 0.46,P=0.039)和放疗(HR 0.34,P=0.046)等局部区域治疗与OS改善独立相关。

临床怎么用

  • 作者认为,仅远处淋巴结转移的宫颈癌提示为局部区域晚期阶段,不同于其他IVB期形式,可通过强化局部区域治疗达到治愈。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Current staging systems classify distant lymph node metastasis (DLM) in cervical cancer as stage IVB, typically treated with systemic therapy. We aim to assess if patients with DLM have different survival rates than those with other stage IVB cervical cancer forms. METHODS: This study included patients diagnosed with metastatic cervical cancer from 2000 to 2021, divided into three groups: para-aortic lymph node metastasis (PaLM), DLM, and distant organ metastasis (DM). Kaplan-Meier analyses estimated cervical cancer-specific (CCSS) and overall survival (OS). A 1:1 propensity-score match between DLM and PaLM patients used logistic regression. Univariate and multivariate Cox analyses identified prognostic risk factors. RESULTS: Of the included 6241 patients, 2079 (33.3 %) were diagnosed with PaLM only, 631 (10.1 %) with DLM only, and 3531 (56.6 %) had DM. Multivariate Cox regression analysis indicated that patients with DLM exhibited comparable CCSS (HR, 0.91; P = 0.28) and OS (HR, 0.93; P = 0.34) to those with PaLM. In contrast, compared to patients with DM, the DLM cohort demonstrated significantly improved CCSS (HR, 0.54; P < 0.001) and OS (HR, 0.58; P < 0.001). Following matching, the CCSS (HR, 0.96; P = 0.70) and OS (HR, 0.95; P = 0.61) of patients with DLM remained comparable to those with PaLM. Among the 632 patients with DLM, locoregional treatments such as total hysterectomy (HR, 0.46; P = 0.039) and radiotherapy (HR, 0.34; P = 0.046) were independently associated with improved OS. CONCLUSION: In cervical cancer, metastasis confined to distant lymph nodes indicates a locoregionally advanced stage, distinct from other stage IVB forms, and can be treated curatively with intensive locoregional therapy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Gu J, Zheng W, Li F, et al. Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node metastasis which is comparable to stage IIIC. Gynecol Oncol. 2025. PMID: 40403519. doi:10.1016/j.ygyno.2025.05.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。